Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

References for PMC Articles for PubMed (Select 19487644)

1.

Glucose and C-peptide changes in the perionset period of type 1 diabetes in the Diabetes Prevention Trial-Type 1.

Sosenko JM, Palmer JP, Rafkin-Mervis L, Krischer JP, Cuthbertson D, Matheson D, Skyler JS.

Diabetes Care. 2008 Nov;31(11):2188-92. doi: 10.2337/dc08-0935. Epub 2008 Jul 23.

2.

Update in type 1 diabetes.

Eisenbarth GS.

J Clin Endocrinol Metab. 2007 Jul;92(7):2403-7. Review.

PMID:
17616634
3.

Prediction and prevention of type 1 diabetes: progress, problems, and prospects.

Skyler JS.

Clin Pharmacol Ther. 2007 May;81(5):768-71. Epub 2007 Mar 28. Review.

PMID:
17392722
4.

Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1.

Sosenko JM, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS; Diabetes Prevention Trial-Type 1 Study Group.

Diabetes Care. 2007 Jan;30(1):38-42.

PMID:
17192330
5.

Pre-type 1 diabetes dysmetabolism: maximal sensitivity achieved with both oral and intravenous glucose tolerance testing.

Barker JM, McFann K, Harrison LC, Fourlanos S, Krischer J, Cuthbertson D, Chase HP, Eisenbarth GS; DPT-1 Study Group.

J Pediatr. 2007 Jan;150(1):31-36.e6.

6.

Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk.

Bingley PJ, Gale EA; European Nicotinamide Diabetes Intervention Trial (ENDIT) Group.

Diabetologia. 2006 May;49(5):881-90. Epub 2006 Mar 3.

PMID:
16514546
7.

Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1.

Sosenko JM, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS.

Diabetes Care. 2006 Mar;29(3):643-9.

PMID:
16505520
8.

Natural history of beta-cell function in type 1 diabetes.

Sherry NA, Tsai EB, Herold KC.

Diabetes. 2005 Dec;54 Suppl 2:S32-9. Review.

9.

Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.

Skyler JS, Krischer JP, Wolfsdorf J, Cowie C, Palmer JP, Greenbaum C, Cuthbertson D, Rafkin-Mervis LE, Chase HP, Leschek E.

Diabetes Care. 2005 May;28(5):1068-76.

PMID:
15855569
10.

Insulin secretion in type 1 diabetes.

Steele C, Hagopian WA, Gitelman S, Masharani U, Cavaghan M, Rother KI, Donaldson D, Harlan DM, Bluestone J, Herold KC.

Diabetes. 2004 Feb;53(2):426-33.

11.

Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes.

Krischer JP, Cuthbertson DD, Yu L, Orban T, Maclaren N, Jackson R, Winter WE, Schatz DA, Palmer JP, Eisenbarth GS.

J Clin Endocrinol Metab. 2003 Jan;88(1):103-8.

PMID:
12519837
12.

Effects of insulin in relatives of patients with type 1 diabetes mellitus.

Diabetes Prevention Trial--Type 1 Diabetes Study Group.

N Engl J Med. 2002 May 30;346(22):1685-91.

13.

Ten-year prognosis of impaired glucose tolerance in siblings of patients with insulin-dependent diabetes.

Rosenbloom AL, Hunt SS, Rosenbloom EK, Maclaren NK.

Diabetes. 1982 May;31(5 Pt 1):385-7.

PMID:
6759254
14.

Impaired glucose tolerance precedes but does not predict insulin-dependent diabetes mellitus: a study of identical twins.

Beer SF, Heaton DA, Alberti KG, Pyke DA, Leslie RD.

Diabetologia. 1990 Aug;33(8):497-502.

PMID:
2210123
15.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk